Pfizer News - August 2026
OrbiMed Advisors Exits Pfizer Stake, Sells 1.95M Shares
Healthcare-focused investment firm OrbiMed Advisors completely sold off its stake in Pfizer (PFE), according to a quarterly disclosure filed on August 14,...
Pfizer's second quarter revenue of $15.0B beat estimates, prompting a raised FY2026 outlook.
Pfizer reported second quarter 2026 revenues of $15.0 billion and an adjusted EPS of $0.77, beating analyst expectations. On a GAAP basis, the company reported...
Pfizer Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Pfizer is projected to report Q2 2026 revenue of $14.43 billion and adjusted EPS of $0.68, as the stock trades near $25.10 relative to a $28.75 analyst...